0001213900-22-054681.txt : 20220908 0001213900-22-054681.hdr.sgml : 20220908 20220908090616 ACCESSION NUMBER: 0001213900-22-054681 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20220908 FILED AS OF DATE: 20220908 DATE AS OF CHANGE: 20220908 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medigus Ltd. CENTRAL INDEX KEY: 0001618500 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37381 FILM NUMBER: 221232682 BUSINESS ADDRESS: STREET 1: 3 HANECHOSHET STREET, BUILDING B CITY: TEL AVIV STATE: L3 ZIP: 6971068 BUSINESS PHONE: 972722602211 MAIL ADDRESS: STREET 1: 3 HANECHOSHET STREET, BUILDING B CITY: TEL AVIV STATE: L3 ZIP: 6971068 6-K 1 ea165488-6k_medigusltd.htm REPORT OF FOREIGN PRIVATE ISSUER

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2022

Commission File Number 001-37381

MEDIGUS LTD.
(Translation of registrant’s name into English)

3 HaNechoshet Street, Building B, 6971068, Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __

EXPLANATORY NOTE

On September 8, 2022, Medigus Ltd. issued a press release titled: “Medigus Board Files a Motion to Approve an Up to $1.6 Million Dividend Distribution.” A copy of this press release is furnished herewith as Exhibit 99.1.

EXHIBIT INDEX

Exhibit		Description
99.1		Press release dated September 8, 2022

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MEDIGUS LTD.

Date: September 8, 2022	By:	/s/ Tali Dinar
		Tali Dinar
		Chief Financial Officer

EX-99.1 2 ea165488ex99-1_medigusltd.htm PRESS RELEASE DATED SEPTEMBER 8, 2022

Exhibit 99.1

Medigus Board Files a Motion to Approve an Up to $1.6 Million Dividend Distribution

Tel Aviv, Israel – September 8, 2022 (GLOBE NEWSWIRE) Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that the Company filed a motion with the Tel Aviv District Court Economic Department for approval of a dividend distribution of up to $1.6 million.

The Company’s motion, if approved as requested, would permit the Company to distribute a dividend to the holders of the Company’s American Depositary Shares in proportion to their respective holdings. A separate announcement would be made if the Company’s board of directors were to declare such a dividend.

Medigus is seeking a court approval for a dividend distribution (as opposed to a share buyback) in light of various legal restrictions that nullified its ability to buy back its shares under a previous court approval for a buyback.

About Medigus

Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce and electric vehicle markets. Medigus’ affiliations in the medical solutions arena include ownership in Polyrizon Ltd. and ownership in industry 4.0 company, ScoutCam Inc. The Company’s affiliates in digital commerce include Gix Internet Ltd., Jeffs’ Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics Ltd. and Revoltz Ltd. are also part of the Company’s portfolio of technology solution providers. To learn more about Medigus’ advanced technologies, please visit http://www.medigus.com/.

Forward-Looking Statements

his press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on Medigus’ current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Medigus undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Medigus is not responsible for the contents of third-party websites.

Company Contact:

Tali Dinar

Chief Financial Officer

+972-8-6466-880

ir@medigus.com

Investor Relations Contact:

Dave Gentry

RedChip Companies Inc.

1-800-RED-CHIP (733-2447)

Or 407-491-4498

MDGS@redchip.com

GRAPHIC 3 ex99-1_001.jpg GRAPHIC begin 644 ex99-1_001.jpg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